When does this change take effect?

This change is effective Dec 10, 2025.

CommercialCoverageMedium impact

08.01.91a, Inclisiran (Leqvio®)

Q: Who is affected by this change?

This affects Independence Blue Cross Cardiology, Endocrinology, Internal Medicine, Family Medicine providers on Commercial plans.

Independence Blue Cross·Cardiology, Endocrinology, Internal Medicine +1 more·Pharmacy

Effective date

Dec 10, 2025

We identified it

Jun 19, 2026

Days to comply

—

Summary

The Inclisiran (Leqvio®) pharmacy policy has been reissued with updates effective December 10, 2025. This is a commercial insurance policy change affecting coverage or billing requirements for this cholesterol-lowering medication.

Action Required

Action needed

By December 10, 2025: Review the updated Inclisiran (Leqvio®) policy at the provided URL to identify specific changes to prior authorization requirements, coverage criteria, or billing procedures. Update billing protocols and provider documentation requirements accordingly for commercial plans.

Related policy hubs

Independence Blue Cross policies Cardiology Endocrinology Internal Medicine Family Medicine